APA (7th ed.) Citation

Lauko, A., Kotecha, R., Barnett, A., Li, H., Tatineni, V., Ali, A., . . . Ahluwalia, M. S. (2021). Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases. Scientific Reports, 11(1), 1. https://doi.org/10.1038/s41598-021-97566-z

Chicago Style (17th ed.) Citation

Lauko, Adam, et al. "Impact of KRAS Mutation Status on the Efficacy of Immunotherapy in Lung Cancer Brain Metastases." Scientific Reports 11, no. 1 (2021): 1. https://doi.org/10.1038/s41598-021-97566-z.

MLA (9th ed.) Citation

Lauko, Adam, et al. "Impact of KRAS Mutation Status on the Efficacy of Immunotherapy in Lung Cancer Brain Metastases." Scientific Reports, vol. 11, no. 1, 2021, p. 1, https://doi.org/10.1038/s41598-021-97566-z.